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Abstract
Background: The associations between adiposity and metabolic risk factors have been suggested to vary across
ethnicities. Studies in Caucasians have shown that after adjusting for waist circumference and body mass index
(BMI), a larger hip circumference may be protective for metabolic risk factors. To our knowledge, these asso-
ciations have never been examined in a Chinese population.
Methods: Baseline (1987–1988) and follow-up (1993–1994) data were from the People’s Republic of China Study
(n¼ 1,144 men, n¼ 1,776 women). Logistic models were stratified by sex and adjusted for age, smoking, center,
and education. Incidence differences (ID) comparing the sex specific 85th percentile to the 15th percentile of hip
circumference were computed for elevated blood pressure, blood glucose and triglycerides, low high-density
lipoprotein cholesterol (HDL-C), and multiple metabolic abnormalities (three or more of the aforementioned).
Results: In models adjusted for waist circumference and BMI, the ID [95% confidence interval (CI)] per 1,000
persons associated with a 12-cm larger hip were 132 (237, 26) for low HDL-C; 85 (138, 31) for elevated
triglycerides; and 49 (83, 4) for multiple metabolic abnormalities. In males, a larger hip circumference was
not associated with a reduction of incident risk factors, although the ID tended to be negative.
Conclusions: In Chinese women, greater mass in the lower trunk region was inversely associated with incident
high triglycerides, low HDL-C, and multiple metabolic abnormalities when adjusted for general and central
adiposity. This association was not detected in men. Additional research is needed to better understand the
mechanisms by which fat at different depots results in differential risk.
Introduction
Specific fat depots may be more closely related to met-abolic risk than overall adiposity.1 Many studies have
used the ratio of waist and hip circumferences as a means of
capturing aspects of body shape that are poorly detected by
body mass index (BMI). Nevertheless, the waist-to-hip ra-
tio does not differentiate the independent effects of hip
and waist circumferences, and the ratio measure does not
account for possible nonlinear associations between the two
anthropometrics.2,3
Although waist and hip circumferences are crude mea-
sures of adipose tissue distribution, the circumference mea-
sures show a high association with the size of the respective
fat depots,4–6 and they are clinically practical due to the low
risk of assessment to patients, low cost, and ease of collec-
tion. Waist circumference is an indicator of the amount of
visceral and subcutaneous adiposity around the abdomen,
while hip circumference assesses skeletal frame size and
adipose and muscle mass in the buttock and thigh regions
(gluteofemoral).7,8 In mutually adjusted models, waist cir-
cumference has been shown to correlate with abdominal
visceral and subcutaneous adiposity and hip circumference
was inversely correlated with those depots but positively
correlated with leg fat mass.8 Visceral and subcutaneous
adipocytes have different lipolytic activities because visceral
fat is associated with adverse cardiovascular risk factors and
is more metabolically active compared with adipocytes in
subcutaneous fat.6
In contrast to a large waist circumference at a given overall
body size, a large hip circumference has been suggested to be
less associated with risk of disease and even potentially
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protective. After adjustment for one another and for BMI,
waist and hip circumferences have been shown to have in-
dependent and opposite associations with cardiovascular
risk factors, coronary heart disease (CHD), cardiovascular
disease (CVD), and mortality.6,9–23 Studies examining com-
ponents of hip and waist circumferences, specifically, leg and
trunk fat, and leg lean mass, using dual-energy X-ray ab-
sorptiometry (DXA) or computed tomography (CT) have
found positive associations of trunk fat and inverse associ-
ations of thigh or leg fat with insulin resistance, dyslipide-
mia, diabetes, and other metabolic risk factors. These
associations have been observed in black, white, and Japa-
nese populations.8,22,24–27
To our knowledge, no studies have evaluated the associ-
ation of hip circumference, independent of waist circumfer-
ence or BMI, with cardiovascular risk factors in a Chinese
population. It is well established that adiposity is associated
with metabolic risk. Because Chinese have greater adiposity
at the same level of BMI compared to non-Asian populations
and experience metabolic abnormalities at low levels of ad-
iposity,28–30 it is uncertain whether an inverse association of
hip circumference with metabolic risk factors would be ob-
served in a Chinese population. Our goal was to explore
whether a larger hip circumference, when controlling for
waist circumference or BMI, would be associated with a




Data were from the community-based People’s Republic
of China (PRC) Study.31 Waist and hip circumferences were
collected from subjects living in urban and rural areas of
Guangzhou, China (southern). Baseline and follow-up ex-
aminations were in 1987–1988 and 1993–1994, respectively.
Participants were aged 28–69 years at baseline.
Of the n¼ 3,019 eligible subjects, participants were ex-
cluded if missing anthropometric data at baseline (n¼ 52) or
follow up (n¼ 15), missing education at baseline (n¼ 1), self-
report of cancer (n¼ 13), or CHD (n¼ 18). Following these
exclusions, 1,144 men and 1,776 women were included in the
analyses. For each of the incident outcomes examined,
prevalent cases of the condition were excluded. This study
was approved by the Institutional Review Board (IRB) at
each field center, and the analysis was approved by the
University of North Carolina at Chapel Hill (UNC-CH) IRB
on research involving human subjects.
Measurements
Protocols and training manuals for measurements and the
review, processing, and analyses of data were administered
by the Collaborative Studies Coordinating Center at UNC-CH.
Data were collected in examination centers by trained per-
sonnel. Participants wore light clothing without shoes during
collection of anthropometric data. Height was measured to
the nearest centimeter (cm) and weight to the nearest kilo-
gram (kg). BMI was calculated [weight (kg)/height (m)2].
Circumferences of the waist and hip were measured to the
nearest 0.1 cm. Waist circumference was measured by pass-
ing the tape measure through the midpoint between the
superior iliac crest and the lowest rib. Hip circumference was
measured at the maximum protrusion.
Subjects were instructed to fast 12 h prior to the exami-
nation. Glucose assays were performed on an Abbott auto-
analyzer. Serum glucose was measured by the hexokinase/
glucose-6-phosphate dehydrogenase method. High-density
lipoprotein cholesterol (HDL-C) and triglycerides (TG) were
measured according to protocols by the Lipid Standardiza-
tion Program of the U.S. National Heart, Lung and Blood
Institute (NHLBI) and Centers for Disease Control (CDC).
Serum TG was determined with use of an enzymic reagent
from Abbott Laboratories. Serum HDL-C was measured
using the Boehringer Mannheim Diagnostics high-perfor-
mance enzymic reagent calibrated with precise standards on
the Abbott analyzer after precipitation of other lipid fractions
with dextran sulfate. To ensure quality control, random
samples were analyzed by the CDC.
Blood pressure was measured three times at each visit
using a random zero mercury sphygmomanometer on the
right arm with the participant seated. The average of the last
two measurements was used in the analyses. Participants
self-reported use of antihypertension medications in the
previous 2 weeks.
Definition of outcomes
Outcomes were dichotomized based on criteria from the
Adult Treatment Panel III (ATP III) of the National Choles-
terol Education Program (NCEP) for metabolic syndrome.32
Components of the metabolic syndrome were defined as: (1)
HDL-C <1.03 mmol/L in males or <1.29 mmol/L in females,
(2) triglycerides 1.7 mmol/L, (3) fasting blood glucose
5.6 mmol/L or self-reported diabetes, and (4) blood pres-
sure 130/85 mmHg or self-report of current antihyperten-
sive medication use. The fifth criterion of the metabolic
syndrome is a large waist circumference. Because waist cir-
cumference was included as a covariate in our models, we
did not model it as an outcome. Instead we assessed a
clustering of risk factors similar to the ATP III metabolic
syndrome definition but exclusive of waist circumference,
which we termed ‘‘multiple metabolic abnormalities’’ and
defined as the presence of at least three of the four afore-
mentioned ATP III outcomes examined.
Statistical analyses
Models were stratified by gender because of the well-
known differences in body shape between men and wom-
en.33 Dichotomous outcomes were coded as 0 (no disease) or 1
(incident disease). All models include the covariates field
center (urban or rural), age (years), and highest education
level attained (less than senior middle school, senior middle
school, more than senior middle school). For all outcomes,
the covariates for smoking, alcohol, menopausal status, and
physical activity were examined but were not included
because associations were small, not statistically significant
( p< 0.05), and did not influence the coefficients associated
with variables of interest.
Quadratic terms were tested to assess nonlinear associa-
tions of BMI, waist circumference, hip circumference, and
age with metabolic risk factors. Most quadratic terms were
not significant at p< 0.05, except for age,2 which improved
model fit significantly in women. Interactions between hip
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circumference and age as well as hip circumference and BMI
were assessed for each outcome using the Wald test with one
degree of freedom, and none were significant at p< 0.05. The
adjusted incidence at the sex-specific 15th percentile of hip
circumference and the incidence differences (ID) comparing
the sex-specific 85th percentile to the 15th percentile of hip
circumference were computed. ID estimates were obtained
from logistic regression models, and 95% confidence inter-
vals (CI) were calculated using the delta method by the
prvalue command in Stata 10.0.34,35 The incidence and ID
were also modeled with adjustment for additional anthro-
pometric measures (waist circumference and BMI). The ID
was standardized to the mean covariate values for continu-
ous variables and to the most prevalent education level
(<senior middle school) and center (rural).
Results
The distribution of most demographic characteristics was
similar between the sexes, except for alcohol and smoking
status (Table 1). A small percentage of women consumed
alcohol (15.1%) or smoked (3.0%), whereas men were much
more likely to drink (59.4%) or smoke (66.1%). The majority
of subjects were normal weight or underweight and did not
have abdominal obesity according to standard World Health
Organization (WHO) BMI definitions and Asian central
obesity cut points of 90 cm in males and 80 cm in females
(Table 1). In this sample, the Pearson correlation coefficients
for waist circumference, hip circumference, and BMI were
high and ranged from 0.76 to 0.83 in men and 0.79 to 0.87
in women. Despite the high correlations, collinearity of
anthropometric measures, evaluated using a variance infla-
tion factor (VIF) were all less than 5.0, well below the crite-
rion for indication of 10.0.
The unadjusted baseline prevalence and 6-year incidence
for each outcome as well as markers of adiposity are shown
in Table 2. In both women and men, multiple metabolic
abnormalities and elevated blood glucose were the least
prevalent outcomes (<10%); however, the crude prevalence
and incidence levels were higher, between 10% and 34%, for
elevated blood pressure, low HDL-C, and elevated triglyc-
erides. The adjusted incidences of metabolic risk factors at
the 15th percentile of hip circumference are shown in Table 3
and the incidence difference (between the 85th and 15th per-
centile of hip circumference (a difference of 11 cm in males
and 12 cm in females) per 1,000 persons are shown in Fig. 1,
A and B. Hip circumference was positively associated with
incident outcomes when it was the only anthropometric
Table 1. Baseline Characteristics Among Chinese Women and Men, the People’s Republic
of China Study (1987–1988)
Women Men
Variables (n¼ 1,776) (n¼ 1,144)
Age (years), mean (SD) 44.8 (8.0) 45.1 (8.3)
Body mass index (kg/m2), mean (SD) 21.0 (2.8) 20.6 (2.5)
Body mass index category (%)
<18.5 kg/m2 18.2 18.9
18.5 to <23.0 kg/m2 62.6 65.4
23.0 to <25.0 kg/m2 10.8 10.1
25.0 to <27.5 kg/m2 5.9 4.3
27.5 to <30.0 kg/m2 1.7 1.1
30.0 to <32.5 kg/m2 0.5 0.4
32.5 kg/m2 0 0
Waist circumference (cm), mean (SD) 70.5 (7.8) 73.2 (7.6)
Central obesitya (%) 13.4 3.4
Hip circumference (cm), mean (SD) 88.1 (6.3) 87.4 (5.4)
Hip circumference, 15th percentile (cm) 82.0 82.0
Hip circumference, 85th percentile (cm) 94.0 93.0
Current cigarette or leaf smokers (%) 3.0 66.1






<Senior middle school 82.2 79.0
Senior middle school 14.6 17.6
>Senior middle school 3.2 3.4
Center (rural) (%) 56.6 59.7
Systolic blood pressure (mmHg), mean (SD) 112.1 (15.8) 113.3 (14.8)
Diastolic blood pressure (mmHg), mean (SD) 72.0 (9.5) 73.6 (9.9)
Glucose (mmol/L), mean (SD) 4.4 (1.1) 4.1 (0.9)
HDL-C (mmol/L), mean (SD) 1.4 (0.3) 1.4 (0.4)
Triglycerides (mmol/L), mean (SD) 1.3 (1.0) 1.3 (1.1)
aAccording to the World Health Organization (WHO) guidelines for Asians, central obesity is defined as a waist circumference  90 cm in
males and  80 cm in females.
SD, standard deviation; HDL-C, high-density lipoprotein cholesterol.
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measure included in the model (model 1). When adjusted
for waist circumference (model 2) or BMI (model 3), the
ID tended to be null or negative, suggesting hip circumference
may be neutral or inversely associated with incident
metabolic risk factors when accounting for general or central
adiposity. In women (Fig. 1A), with adjustment for waist
circumference, a larger hip circumference was associated with
a significant decrease in incidence (95% CI) per 1,000 persons
for high triglycerides 74 (120, 27) and low HDL-C 114
(207, 21); and when adjusting for BMI, hip circumference
was associated with a significant decrease in incidence per
1,000 persons for high triglycerides 56 (108, 4) and
multiple metabolic abnormalities 37 (69, 5). In males
(Fig. 1B), ID estimates for models 2 and 3 tended to be null or
negative.
Model 4 included hip and was adjusted for both waist
circumference and BMI. In women, the ID (95% CI) per 1,000
persons was 85 (138, 31) for incident high triglycerides,
132 (237, 26) for low HDL-C and 49 (83, 14) for
multiple metabolic abnormalities. For blood pressure and
glucose, estimates were negative but confidence intervals
included zero. In men, point estimates for all the out-
comes examined were negative and the confidence intervals
included zero.
Additional sex-stratified regression models were run to
examine the association of hip circumference with incident
hypertension and diabetes. Results suggest a larger hip cir-
cumference was not associated with a greater incidence of
diabetes or hypertension.
Discussion
In this prospective study, hip circumference was posi-
tively associated with incident metabolic risk factors in
Chinese men and women. After adjustment for waist cir-
cumference and BMI, women with a larger hip circumference
had a lower risk of incident elevated TGs, low HDL-C, and
multiple metabolic abnormalities, and null associations were
Table 2. Crude Baseline Prevalence and 6-Year Incidence of Adiposity
and Metabolic Abnormalities Among Chinese Women and Men
Women Men
Prevalence % Incidence % Prevalence % Incidence %
Elevated BMI (25 kg/m2) 9.7 6.7 5.7 7.0
Central obesitya (waist circumference 80 cm in women and 90 cm
in men)
13.4 11.2 3.4 4.1
Elevated blood pressure (130/85 mmHg or medication) 15.2 23.6 17.2 30.2
Elevated glucose (5.6 mmol/L) 9.6 13.1 7.5 8.6
Low HDL-C (<1.29 mmol/L in women; <1.03 mmol/L in men) 34.3 32.8 15.0 13.3
Elevated triglycerides (1.7 mmol/L) 23.9 11.1 22.1 15.8
Multiple metabolic abnormalities (3 of the above criteria) 5.0 8.8 2.4 6.1
aAccording to the World Health Organization (WHO) guidelines for Asians and the IOTF metabolic syndrome definition for Chinese.
BMI, body mass index; HDL-C, high-density lipoprotein cholesterol; IOTF, International Obesity Task Force.
Table 3. Incidence of Metabolic Abnormalities per 1,000 Persons (95% CI) at the 15th Percentilea of Hip
Model 1 Model 2 Model 3 Model 4
Risk at the 15th percentile of hipa (95% CI) Model 1b (Model 1b þ waist) (Model 1b þ BMI)
(Model 1b þ waist
þ BMI)
Women
Elevated blood pressure (130/85 mmHg
or antihypertensive medication use)
191 (161, 220) 237 (194, 281) 233 (188, 278) 246 (198, 294)
Elevated glucose (5.6 mmol/L) 96 (75, 117) 122 (90, 155) 115 (82, 147) 123 (88, 158)
Low HDL-C (<1.29 mmol/L) 295 (257, 334) 380 (323, 437) 366 (306, 427) 389 (326, 453)
Elevated triglycerides (1.7 mmol/L) 75 (56, 95) 128 (92, 163) 120 (84, 156) 135 (95, 176)
Multiple metabolic abnormalities
(3 of the above criteria)
42 (29, 55) 70 (46, 93) 74 (49, 100) 81 (53, 110)
Men
Elevated blood pressure (130/85 mmHg
or antihypertensive medication use)
220 (183, 258) 274 (219, 328) 279 (225, 333) 292 (233, 350)
Elevated glucose (5.6 mmol/L) 56 (37, 75) 86 (51, 121) 84 (52, 117) 95 (56, 134)
Low HDL-C (<1.03 mmol/L) 87 (63, 110) 138 (95, 180) 124 (85, 162) 144 (99, 190)
Elevated triglycerides (1.7 mmol/L) 112 (84, 141) 179 (129, 228) 150 (107, 193) 182 (130, 234)
Multiple metabolic abnormalities (3
of the above criteria)
21 (11, 31) 47 (24, 71) 40 (20, 59) 53 (26, 80)
aThe 15th percentile of hip is 82 cm in men and in women.
bModel 1 includes hip, age, smoking, center, and education. For women, this model also includes age.2
CI, confidence interval; BMI, body mass index; HDL-C, high-density lipoprotein cholesterol.
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found for elevated blood pressure and elevated glucose.
In men, after adjustment for waist circumference or waist
circumference and BMI, the association of hip circumference
with glucose, lipid levels, and multiple metabolic abnor-
malities was inverse, but not statistically significant. Weaker
inverse associations in men are consistent with other studies,
many of which found stronger evidence of an inverse
association of hip circumference with adverse outcomes in
women10,16,18,20,36 This differential may be due to gender
differences in hip girth, body composition, and/or fat dis-
tribution. Although the gender differences in hip circumfer-
ence are smaller in Chinese compared to Caucasians, gender
differences in body shape and fat distribution persist.37 In
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Model 1: hip Model 2: Model 1 + waist Model 3: Model 1 + BMI Model 4: Model 1 + waist + BMI
Elevated blood Elevated glucose Low HDL-C Elevated Multiple metabolic 
pressure triglycerides abnormalities
B
FIG. 1. (A) Incidence difference [95% confidence interval (CI)] per 1,000 persons for metabolic abnormalities at the 15th
versus 85th percentile of hip circumference in women. All models were adjusted for baseline age, age2, education level,
smoking status, and field center. Multiple metabolic abnormalities were defined as the presence of three or more metabolic
abnormalities [elevated blood pressure, elevated glucose, low high-density lipoprotein cholesterol (HDL-C) and elevated
triglycerides]. The 15th and 85th percentiles of hip were 82 cm and 94 cm, respectively. (B) Incidence difference (95% CI) per
1,000 persons for metabolic abnormalities at the 15th versus 85th percentile of hip circumference in men. All models were
adjusted for baseline age, education level, smoking status, and field center. Multiple metabolic abnormalities were defined as
the presence of three or more metabolic abnormalities (elevated blood pressure, elevated glucose, low HDL-C, and elevated
triglycerides). The 15th and 85th percentiles of hip were 82 cm and 93 cm, respectively.
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women and men was less than 1 cm, whereas most studies in
Caucasian populations have shown gender differences in hip
circumference between 1 and 6 cm.8,12,15 We explored whe-
ther gender differences were related to differences in height,
but when height was added to the models, the estimates
remained essentially unchanged.
The participants in our study were leaner than popula-
tions examined in previous studies of hip circumference, yet
associations between hip circumference and metabolic risk
factors were observed. Here the mean BMI among Chinese
was 20.6 kg/m2 in men and 21.0 kg/m2 in women, and fewer
than 6% of men and 10% of women had a BMI of 25 kg/m2
and above, whereas in most studies the mean BMI was
25 kg/m2.9,11–15,17,21,36,38 A recent study36 that reported an
inverse association of hip circumference with incident dia-
betes and CHD included data from American whites and
blacks in whom the mean value for hip circumference within
the lowest quintile of hip circumference (92.7 cm) was larger
than our overall population mean for hip circumference
(87.8 cm). The sex-specific mean value of hip circumference
in our population was also smaller than means reported in
previously published studies.9,11–15,17,21,36,38
We know of six studies that have used a cross-sectional
design to examine the association of hip circumference with
metabolic syndrome or its component risk factors (blood
pressure, lipids, and glucose).10,12,13,16,21,22,38 Two of these
studies were conducted among Australians.13,21 Dixon
et al.21 examined obese Australian women and used receiver
operating characteristic (ROC) curves to identify the values
of hip and waist circumferences associated with the highest
sum of sensitivity and specificity for the presence of meta-
bolic syndrome. They then tested the odds of metabolic
syndrome above versus below that cutoff. The investigators
found a small hip circumference (below the cutoff of 115 cm)
was associated with greater odds of the metabolic syndrome
[odds ratio (OR) (95% CI): 12.3 (3.0, 51.0)] compared to a
large hip circumference (above the cutoff of 115 cm). The
Australian Diabetes, Obesity and Lifestyle study,13 a na-
tionally representative study among 11,247 participants aged
25 and older, found that the OR (95% CI) associated with a 1
standard deviation (SD) increase in hip circumference (7.6 cm
in men and 11.1 cm in women) was 0.55 (0.41, 0.73) in men
and 0.42 (0.27, 0.65) in women for diabetes; 0.58 (0.50, 0.67) in
men and 0.37 (0.30, 0.45) in women for dyslipidemia; and
0.80 (0.69, 0.93) in men and 0.88 (0.70, 1.11) in women for
hypertension.
The Quebec Family Study examined the association of hip
circumference with metabolic risk factors by modeling hip
circumference as a continuous variable.12 Models were ad-
justed for age, BMI, and waist circumference. In men, a 1-cm
increase in hip circumference was associated with higher
levels of HDL-C [mean SD 0.008 0.004 mmol/L] and
lower levels of triglycerides (0.039 0.011 mmol/L) and
glucose (0.039 0.018 mmol/L). Associations were positive,
but not significant, for blood pressure. In women, only the
association of a 1-cm increase in hip circumference with tri-
glycerides (0.017 0.006 mmol/L) was significant. Asso-
ciations were inverse, but not significant, for blood pressure.
Two papers summarized results from a cross-sectional
study of Caucasians in Tehran, Iran.10,16 Quintiles of hip
circumference were used to predict the OR for ATP III
metabolic syndrome components among 5,720 women10 and
4,040 men16 aged 18–74. In women, the adjusted OR com-
paring the largest versus smallest hip circumference quintile
was inversely associated with all components of the meta-
bolic syndrome, and in men this was true for all outcomes
except elevated blood pressure.
A cross-sectional study that examined the association
of hip circumference with metabolic risk factors in non-
Caucasians included Melanesians, Micronesians, Indians,
and Creoles from Mauritius, Rodrigues, Papua New Guinea,
and Nauru.38 In all four ethnic groups, a 1 SD larger hip
circumference (6.9–11.8 cm in men and 9.7–13.6 cm in
women) was associated with lower glucose and TG levels in
both sexes and higher HDL-C levels in women only, after
adjustment for waist circumference, BMI, and age. Inverse
associations with blood pressure were not significant.
To our knowledge the only other study of hip circumfer-
ence that included a large East Asian sample used anthro-
pometry and DXA to examine the cross-sectional association
of hip circumference and depots of lean and fat mass with
cardiovascular risk factors.22 Participants included Japanese
men (n¼ 1,249) and women (n¼ 3,007) aged 20–79 years.
A 1-cm increase in hip circumference was associated with
a decrease in the odds—OR (95% CI) for males and for
females) of hypertension [0.92 (0.87, 0.98) and 0.94 (0.91,
0.98)], low HDL-C [0.91 (0.84, 0.98) and 0.88 (0.81, 0.95)],
hypertriglyceridemia [0.91 (0.87, 0.96) and 0.97 (0.93, 1.01)],
dyslipidemia [0.92 (0.87, 0.96) and 0.96 (0.93, 0.98)], and di-
abetes [0.88 (0.79, 0.97) and 0.90 (0.84, 0.98)]—when control-
ling for BMI and waist circumference. Further examination of
cardiovascular risk factors with measures of body composi-
tion suggested a positive association of trunk fat mass and a
negative association of leg fat mass with hypertension,
hypertriglyceridemia, dyslipidemia, and diabetes in men. In
women, greater trunk fat mass and lower leg fat mass were
significantly and positively associated with these outcomes as
well as for hypercholesterolemia and low HDL-C.
The six cross-sectional studies presented above support
the inverse association of a larger hip circumference with
metabolic risk factors when controlling for waist circumfer-
ence or BMI. The reduction in risk was generally moderate
with ORs typically in the range of 0.9–0.4 for a 1 SD increase
in hip circumference or for comparison of the highest
to lowest quartile or quintile of hip circumference. Similar
to our study of incidence, the majority of these studies of
prevalence12,13,16,38 found weaker associations of hip cir-
cumference with blood pressure, compared to the association
with other metabolic risk factors. Hypertension is a multi-
genic disease that varies in etiology39,40; therefore, it is pos-
sible that only a subset of individuals with hypertension
have elevated blood pressure as a result of mechanisms
related to fat distribution.
To our knowledge, our study is the first to examine the
prospective association of hip circumference with all meta-
bolic syndrome components. Longitudinal studies examin-
ing the associations with hip circumference have focused on
CHD, CVD, diabetes, or mortality as outcome measures and
none included an East Asian sample. We know of six studies
that have examined longitudinal associations with hip
circumference,11,14,15,17,23,36 all of which support an inverse
association of a larger hip circumference with incident CHD,
CVD, diabetes, and mortality when controlling for central or
general adiposity.
Overall, results from both cross-sectional and longitudinal
studies support an inverse association of a larger hip cir-
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cumference with glucose, lipids, and health outcomes (CHD,
CVD, mortality) and perhaps a weak association with blood
pressure when accounting for general or central adiposity.
Although the causal mechanisms between fat depots and
risk factors are not certain, it has been suggested that in-
flammatory markers and insulin resistance may play an
intermediary role in the link between adipose tissue and
metabolic risk1,41,42 Adipose tissue in the gluteofemoral re-
gion may serve an important role in the removal of nones-
terified fatty acids (NEFA) from the circulation.43,44 This
activity could protect the liver, pancreas, and skeletal muscle
from exposure and accumulation of NEFA and thereby limit
the development of insulin resistance. Thigh subcutaneous
fat has also been correlated with greater insulin sensitivity.45
More research is needed to better understand the underlying
mechanisms in various populations.
This is the first longitudinal study to indicate an inverse
association of a large hip circumference with incident meta-
bolic outcomes in a Chinese population. This population was
unusually lean by Western standards, indicating that high
levels of adiposity are not required for an inverse association
of hip circumference to be detected. It is well established
that excess adiposity is associated with a greater risk for the
metabolic syndrome. However, the distribution of the adi-
posity appears to be indicative of risk. The authors acknowl-
edge the identification of a statistical association does not
prove causation, and the underlying mechanisms for the in-
verse association cannot be discerned based on our study.
Strengths of this work include the quality control of the data
collection, longitudinal design, and use of measured anthro-
pometry. This study is limited in that we did not have more
discriminative measures of body composition such as DXA or
CT scans; the sample was from one city in southern China
during 1987–1994, and the prevalence of obesity has increased
since this time. Further examination of hip circumference with
metabolic abnormalities may help clarify the underlying pa-
thology and differences observed across body weight cate-
gories and gender. Additional research on Chinese
populations that incorporates subjects who are overweight
and obese and includes additional measures of trunk and leg
fat and leg lean mass may provide insight into the mechanistic
role of regional adiposity on metabolic risk factors.
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